back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-01-24 11:15 Tx date 2021-08-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Levine, David
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-85,000 vol |
0 | |
| Filed 2022-01-21 19:09 Tx date 2022-01-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Levine, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+6,500 vol |
11,500 | |
| Filed 2022-01-21 19:08 Tx date 2021-11-23 |
$AGN
Algernon Pharmaceuticals Inc. |
Levine, David
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-495,000 vol |
5,000 | |
| Filed 2022-01-21 19:07 Tx date 2021-11-23 |
$AGN
Algernon Pharmaceuticals Inc. |
Levine, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-142,285 vol |
1,437 | |
| Filed 2021-08-10 23:05 Tx date 2021-02-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Levine, David
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-200,000 vol |
500,000 | |
| Filed 2021-02-04 12:16 Tx date 2021-02-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Levine, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+73,118 vol |
143,722 | |
| Filed 2021-02-04 12:15 Tx date 2021-02-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Levine, David
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-82,500 vol |
85,000 | |
| Filed 2020-12-18 19:40 Tx date 2020-09-29 |
$AGN
Algernon Pharmaceuticals Inc. |
Levine, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+70,604 vol |
70,604 | |
| Filed 2020-12-18 19:39 Tx date 2015-12-14 |
$AGN
Algernon Pharmaceuticals Inc. |
Levine, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-12-18 19:39 Tx date 2020-09-29 |
$AGN
Algernon Pharmaceuticals Inc. |
Levine, David
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-82,500 vol |
167,500 | |
| Filed 2020-08-27 12:16 Tx date 2015-10-26 |
$AGN
Algernon Pharmaceuticals Inc. |
Levine, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
||
| Filed 2020-08-27 12:16 Tx date 2015-12-14 |
$AGN
Algernon Pharmaceuticals Inc. |
Levine, David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2020-08-27 12:14 Tx date 2020-04-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Levine, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
700,000 | |
| Filed 2020-08-27 12:13 Tx date 2020-02-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Levine, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
500,000 | |
| Filed 2020-08-27 12:12 Tx date 2018-03-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Levine, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
300,000 | |
| Filed 2020-08-27 12:11 Tx date 2017-05-18 |
$AGN
Algernon Pharmaceuticals Inc. |
Levine, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
250,000 | |
| Filed 2020-08-27 12:10 Tx date 2015-10-26 |
$AGN
Algernon Pharmaceuticals Inc. |
Levine, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
||
| Filed 2020-08-27 12:09 Tx date 2015-12-14 |
$AGN
Algernon Pharmaceuticals Inc. |
Levine, David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-27 12:08 Tx date 2020-08-21 |
$AGN
Algernon Pharmaceuticals Inc. |
Levine, David
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+250,000 vol |
250,000 | |
| Filed 2020-08-27 12:07 Tx date 2015-12-14 |
$AGN
Algernon Pharmaceuticals Inc. |
Levine, David
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
00 - Opening Balance-Initial SEDI Report
|